Clinical Trials
Source: Solr
- Score: 1Liver
A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)
- Ages18 years and older
- GenderBoth
- Score: 1Endocrine System, Genetics
A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease (GATEWAY)
- Ages18 years - 60 years
- GenderBoth
- Score: 1Digestive System
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
- Ages18 years - 75 years
- GenderBoth
- Score: 1Digestive System
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
- Ages18 years - 75 years
- GenderBoth
- Score: 1Digestive System
Blood and Stool Sample Collection in Subjects with a Diagnosis of Colorectal Cancer or Colorectal Lesion 2018-07 Act Fast
- Ages40 years and older
- GenderBoth
- Score: 1Pancreatic Cancer
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs
- Score: 1Endocrine System
Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis
- Ages18 years - 80 years
- GenderBoth
- Score: 1Digestive System
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Score: 1Digestive System
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
- Ages12 years - 75 years
- GenderBoth
- Score: 1Immune System
Inhibition of Sterile Inflammation by Digoxin
- Ages18 years - 70 years
- GenderBoth